Patient Case 1: Patient with Intermediate Risk Myelofibrosis

Opinion
Video

Medical experts discuss a patient case highlighting a 68-year old woman who is uninterested in transplantation and treatment with ruxolitinib has been initiated.

Related Videos
Related Content